AMPLIRUN® SARS-CoV-2 RNA Control, 50 µl

Vircell AMPLIRUN® SARS-CoV-2 RNA Controls provide purified, quantified RNA from SARS-CoV-2 (including key variants of concern) for use as positive controls in nucleic acid amplification-based techniques. Each control contains the complete viral genome, quantified at 12,500–20,000 copies/µL (qPCR-determined), and is supplied in a lyophilized, non-infectious format with an inactivation certificate.

These controls are designed for PCR, RT-PCR, qPCR, and other molecular testing platforms, ensuring reproducibility, sensitivity, and precision in COVID-19 diagnostics, assay validation, and variant surveillance.

Available Controls

Key Features

• Purified complete genome RNA – independent third-party control material, valid for any platform.
• qPCR quantified – 12,500–20,000 copies/µL for precise calibration.
• Variant-specific controls available – Alpha, Beta, Gamma, Delta, Omicron, Omicron BA.2.
• Non-infectious material – supplied with inactivation certificate for biosafety.
• Lyophilized format – stable, easy to ship/store, no dry ice needed.
• Convenient reconstitution – resuspend with 50 µL Molecular Biology Grade Water (provided).
• Universal compatibility – suitable for PCR, RT-PCR, qPCR, and sequencing workflows.

Applications

• Positive controls for SARS-CoV-2 PCR/RT-PCR/qPCR assays.
• Validation of in-house and commercial COVID-19 diagnostic kits.
• Assay reproducibility, sensitivity, specificity, and LoD testing.
• Absolute quantification via standard curve generation.
• Variant detection and surveillance assay development.
• Reliable alternative to clinical samples in COVID-19 molecular diagnostics.

Product Details

The AMPLIRUN® SARS-CoV-2 RNA Controls provide laboratories with standardized, reproducible positive controls for COVID-19 diagnostics and variant surveillance. With quantified RNA genome copies, variant-specific availability, sequencing data, and a safe lyophilized format, these controls are indispensable for assay validation, diagnostic precision, and quality assurance in molecular virology and pandemic response.